The Project has also submitted resolutions to five major American drug companies. Harvard owns nearly $7 million worth of stock in two of the firms, Merck and Co. and Warner-Lamert Co.

One of the resolutions called for the drug companies to study the effect of their advertising on the drug problem. A second resolution called for the elimination of certain drug labelling abuses. The Project charged that some companies water down or delete the warnings on drugs shipped to foreign countries.

Of the five companies, only Merck and Co. has held their stockholders meeting. Both resolutions were overwhelmingly defeated, with the drug abuse proposal receiving only 2 per cent of the vote and the labelling proposal even less.

In a separate action, the Council for Corporate Review, a Minneapolis-based organization, sponsored a shareholder's resolution requiring five defense contractors--including Honeywell, Inc., and Sperry Kand--to establish Committees on Economic Conversion to plan for a smooth transition from military to civilian production. Harvard owns nearly $5.5 million of stock in these two companies.

On Wednesday, 98.4 per cent of the stockholders at Honeywell's annual meeting voted against the resolution. Another resolution, requesting a detailed report of Honeywell's involvement in the Indochina war, was also overwhelmingly defeated. The resolution had been sponsored by the National Clergy and Laymen Concerned.

Farber said yesterday he will disclose on Monday how the Corporation voted on their various resolutions